In Silico Perspectives on Triple Negative Breast Cancer: Challenges and Progress

QR Code

In Silico Perspectives on Triple Negative Breast Cancer: Challenges and Progress

Triple-negative breast cancer (TNBC) represents a highly aggressive and heterogeneous subtype of breast cancer (BC), lacking estrogen, progesterone, and HER2 receptors, thereby limiting treatment options and contributing to poor prognosis. This review comprehensively explores the evolving landscape...

Full description

Saved in:

Bibliographic Details
Main Authors:	Maham Taqi, Arleen Yousuf, Sidra Shaikh, Faheeda Soomro, Abdul Sattar Qureshi, Kannan RR Rengasamy
Format:	Article
Language:	English
Published:	QAASPA Publisher 2025-06-01
Series:	BioMed Target Journal
Subjects:	triple negative breast cancer molecular docking computational modeling drug discovery
Online Access:	https://qaaspa.com/index.php/bmtj/article/view/96
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Triple – negative essential thrombocythemia in a child: A diagnostic challenge
by: Neha Goel, et al.
Published: (2025-06-01)

Results of combination treatment for triple-negative breast cancer
by: M. A. Sekundova, et al.
Published: (2014-07-01)

Role of Glucocorticoid Receptor in Triple-Negative Breast Cancer
by: Raj Kumar
Published: (2025-04-01)

c-MYC Levels and Metabolic Parameters in Triple-Positive and Triple-Negative Breast Cancer
by: Doaa N. Abood, et al.
Published: (2025-06-01)

Diagnostic utility of ultrasound features in identifying triple-negative breast cancer
by: Jampana Sahitya, et al.
Published: (2025-05-01)

Caveolin-1 in Tumour Cells is Predominately Expressed in the Basal Subtype of Triple-Negative Breast Carcinoma
by: Savelina Popovska, et al.
Published: (2014-11-01)

SHCBP1 drives tumor progression in triple-negative breast cancer
by: Huiling Wang, et al.
Published: (2025-07-01)

Molecular genetic predictors of progression of triple negative breast cancer
by: I. S. Panchenko, et al.
Published: (2025-03-01)

IQGAP1 is a Specific Target of Haldol in Triple Negative Breast Cancer
by: Mahmood Meqdad
Published: (2025-06-01)

Blood mononuclear cell molecular landscape associated with tumor progression in triple-negative breast cancer
by: M. R. Patysheva, et al.
Published: (2023-11-01)

Translational drugs targeting cancer stem cells in triple-negative breast cancer
by: Felipe P. de Oliveira, et al.
Published: (2025-09-01)

MicroRNA-based potential diagnostic, prognostic and therapeutic applications in triple-negative breast cancer
by: Qian Tang, et al.
Published: (2019-12-01)

TOMM40L promotes proliferation and migration of triple negative breast cancer cells and correlates with poor prognosis
by: ZHANG Ke, LU Jiangning, SUN Lixin, YU Long, SUN Lichao, RAN Yuliang
Published: (2025-05-01)

Omitting anthracyclines for the adjuvant treatment of patients with triple-negative breast cancer: A non-inferiority meta-analysis
by: Fabio Girardi, et al.
Published: (2025-10-01)

COMPARATIVE ANALYSIS OF DIFFERENT NEOADJUVANT CHEMOTHERAPY REGIMENS FOR TRIPLE-NEGATIVE BREAST CANCER
by: P. V. Krivorotko, et al.
Published: (2017-12-01)

Clinical case of torpid course of metastatic triple negative breast cancer
by: E. P. Kulikov, et al.
Published: (2022-03-01)

Chemoimmunomodulation in triple negative breast cancer: a key to maximizing anti-PD-1 chemoimmunotherapeutic efficacy
by: Mohammed O. Gbadamosi, et al.
Published: (2025-12-01)

The Role of Genomics and Transcriptomics in Characterizing and Predicting Patient Response to Treatment in Triple Negative Breast Cancer (TNBC)
by: Franklin Eduardo Corea-Dilbert, et al.
Published: (2025-04-01)

Size matters: a review of the challenges in and importance of multimodal approaches to the management of patients with small, node-negative, triple-negative breast cancer
by: Vishnu Prasath, et al.
Published: (2025-07-01)

USP44 promotes chemotherapeutic drug resistance of triple negative breast cancer through EZH2 protein stability
by: Pu Wu, et al.
Published: (2025-12-01)

Effect of body mass index on clinical and morphological characteristics of triple negative breast cancer
by: I. B. Schepotin, et al.
Published: (2014-07-01)

Case Report: Palliative Care for Metastatic triple negative Breast Cancer with Cutaneous Involvement
by: Kaylee Scarnati, et al.
Published: (2025-06-01)

Androgen receptor expression in triple negative breast cancer: an Algerian population study
by: Amel Hedjem, et al.
Published: (2025-12-01)

A Machine-Learning Model for the Prediction of Triple-Negative Breast Cancer Based on Multiparameter MRI
by: Cai Y, et al.
Published: (2025-07-01)

Network‐Based Integrative Analysis to Identify Key Genes and Corresponding Reporter Biomolecules for Triple‐Negative Breast Cancer
by: Pooja Singh, et al.
Published: (2025-05-01)

Novel Thymoquinone Derivative TQFL28 Inhibits Triple-Negative Breast Cancer (TNBC) Invasiveness In Vitro and In Vivo
by: Jiayue He, et al.
Published: (2025-06-01)

Neoadjuvant chemotherapy with or without metformin in early-stage or locally advanced (non-metastatic) triple negative breast cancer—an open-label phase 2 randomized controlled trial
by: Vinod K. Ramani, et al.
Published: (2025-06-01)

Potentiating Antibody-Dependent Cellular Cytotoxicity in Triple-Negative Breast Cancer via the Humanized Anti-CD147 Antibody
by: Kanyarat Thongheang, et al.
Published: (2025-04-01)

Biomimetic tumor cell membrane-camouflaged nanomicelles for synergistic chemo-immunotherapy of Triple-negative breast cancer
by: Xiaoman Xu, et al.
Published: (2025-08-01)

Multifactorial Analysis of Prognostic and Predictive Biomarkers in Triple Negative Breast Cancer Patients
by: V. N. Pavlov, et al.
Published: (2025-07-01)

Correction: Neoadjuvant chemotherapy with or without metformin in early-stage or locally advanced (non-metastatic) triple negative breast cancer—an open-label phase 2 randomized controlled trial
by: Vinod K. Ramani, et al.
Published: (2025-08-01)

Oral microbiome components predict response to neoadjuvant chemotherapy in triple-negative breast cancer patients
by: Xiaoyan Fu, et al.
Published: (2025-07-01)

The Association of Immune Cell Infiltration with Metastasis Location in De Novo Metastatic Triple Negative Breast Cancer: A Multicenter Cross-Sectional Study in Indonesia
by: Jeffry Beta Tenggara, et al.
Published: (2024-01-01)

GGT and GSH-triggered nanoplatform for efficient gambogic acid delivery and tumor penetration in triple-negative breast cancer
by: Su Li, et al.
Published: (2025-08-01)

Pathological complete response of locally advanced triple-negative breast cancer: case report
by: V. V. Konstantinova, et al.
Published: (2024-09-01)

Extracellular Vesicle Proteome Analysis Improves Diagnosis of Recurrence in Triple‐Negative Breast Cancer
by: Ju‐Yong Hyon, et al.
Published: (2025-06-01)

Efficacy and safety of cisplatin and paclitaxel (PlaTax regimen) in the neoadjuvant treatment of patients with stage II–III triple-negative breast cancer
by: O. O. Gordeeva, et al.
Published: (2020-11-01)

Design and synthesis of 3,4-seco-Lupane triterpene derivatives: targeting tumor angiogenesis and inducing apoptosis in triple-negative breast cancer
by: Chunyu Gao, et al.
Published: (2025-07-01)

Integration of chromosome conformation and gene expression networks reveals regulatory mechanisms in triple negative breast cancer
by: Helena Reyes-Gopar, et al.
Published: (2025-07-01)

The role of epidermal growth factor receptor (EGFR) in the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer patients
by: N. N. Babyshkina, et al.
Published: (2020-04-01)